Odontogenic Cysts
Odontogenic Keratocyst
aka OKC · Keratocystic Odontogenic Tumour (WHO 2005) · Primordial Cyst
Developmental odontogenic cyst arising from dental lamina remnants; notable for aggressive behaviour, high recurrence, and association with Gorlin–Goltz syndrome.
Red Flags
- ·Multiple cysts in a patient < 30 years
- ·Rapid recurrence
- ·Cortical perforation with soft-tissue mass
- ·Palmar/plantar pits, jaw cysts, calcified falx = Gorlin
- ·New paraesthesia post-op
Clinical Tips
- ·Never curette an OKC as if it were a simple cyst — the lining separates in shreds and daughter cysts are missed.
- ·Marsupialise first if the lesion is very large or adjacent to IAN; the lining thickens and metaplastic changes make secondary enucleation easier.
- ·Send every jaw cyst for histology; a clinical dentigerous cyst may be an OKC.
Examination Checklist
- ·Full facial and skin exam (BCCs, palmar pits)
- ·Bimanual palpation of jaws
- ·OPG + CBCT
- ·Aspiration cytology
- ·Genetic history for Gorlin
- ·Photograph for records
§ overviewOverview
A benign but locally aggressive developmental odontogenic cyst characterised by a distinctive parakeratinised stratified squamous epithelial lining and marked propensity for recurrence. WHO 2022 reclassified it once again as an odontogenic cyst.
§ icdICD Classification
ICD-10 K09.0
§ etiologyEtiology
- 01Developmental — arises from remnants of dental lamina (rests of Serres)
- 02PTCH1 tumour-suppressor gene mutation (Sonic Hedgehog pathway)
§ riskRisk Factors
- 01Family history of Gorlin–Goltz syndrome
- 02Bifid rib, palmar/plantar pits
- 03Prior mandibular OKC (metachronous recurrence)
§ geneticsGenetics & Molecular Biology
- 01Sporadic OKCs: two-hit inactivation of PTCH1 (9q22.3) in 30–85%
- 02Gorlin–Goltz (NBCCS): germline PTCH1 mutation, autosomal dominant, high penetrance
- 03SUFU and PTCH2 rare variants
- 04Hedgehog pathway upregulation → GLI transcription factors → cell proliferation
§ epidemiologyEpidemiology
5–15% of all odontogenic cysts. Bimodal age distribution (2nd–3rd and 5th decades). M > F (~1.6:1). Mandible 65–83%, especially posterior body/ramus and 3rd molar region.
§ pathogenesisPathogenesis
Loss of PTCH1 releases Smoothened, activating Hedgehog signalling. Rests of Serres proliferate, form microcysts that coalesce. Enlargement is by intrinsic epithelial proliferation and cytokine-mediated bone resorption — not osmotic — explaining growth along medullary bone with minimal cortical expansion.
§ clinicalClinical Features
- 01Often asymptomatic, discovered incidentally on OPG
- 02Painless swelling only when very large
- 03Grows anteroposteriorly along medullary bone — minimal buccolingual expansion
- 04Displacement of teeth, occasional paraesthesia
- 05May be associated with unerupted tooth (mimics dentigerous)
§ signsSigns & Symptoms
- 01Mild swelling, mobile teeth, occasional discharge
- 02In Gorlin syndrome: multiple BCCs, palmar/plantar pits, frontal bossing, calcified falx cerebri, hypertelorism
§ differentialDifferential Diagnosis
- 01Dentigerous cyst
- 02Ameloblastoma (unicystic)
- 03Radicular cyst
- 04Ameloblastic fibroma
- 05Central giant cell granuloma
- 06Traumatic bone cyst
§ criteriaDiagnostic Criteria
- 01Radiolucency with characteristic AP growth
- 02Aspirate protein < 4 g/dL, keratin flakes
- 03Histology: parakeratinised stratified squamous epithelium, 6–8 cells thick, palisaded hyperchromatic basal cells, corrugated luminal surface, flat epithelium–CT interface
§ histopathHistopathology
- 01Uniform 6–8 cell thick parakeratinised stratified squamous epithelium
- 02Prominent palisaded hyperchromatic columnar basal cell layer with reverse polarity
- 03Corrugated (wavy) parakeratotic luminal surface
- 04Flat basement membrane — no rete ridges (predisposes to easy separation and recurrence)
- 05Thin fibrous capsule with satellite (daughter) cysts and epithelial islands
- 06Mitotic figures in suprabasal layer
§ radiographicRadiographic Features
- 01Well-defined corticated radiolucency
- 02Uni- or multilocular ('scalloped' margins in multilocular)
- 03Growth along long axis of mandible with minimal expansion
- 04May be pericoronal (mimics dentigerous), lateral, or interradicular
- 05Root displacement > resorption
§ opgOPG Findings
- 01Best screening view; check for multiplicity (Gorlin)
- 02Scalloping between roots is characteristic
§ cbctCBCT Findings
- 01Assess cortical integrity, IAN canal relation, buccolingual extent, satellite cysts
- 02Small-FOV CBCT gold standard for surgical planning
§ ctCT Findings
- 01For very large lesions with soft-tissue involvement or suspected perforation
§ mriMRI Findings
- 01Homogeneous hyperintensity on T2, intermediate T1; keratin content raises T1 signal vs simple cysts; peripheral rim enhancement only
§ investigationsInvestigations
- 01Aspiration — thick cheesy fluid, keratin flakes, protein < 4 g/dL
- 02Incisional biopsy for histopathological confirmation
- 03Genetic testing for PTCH1 in suspected Gorlin syndrome
- 04Skin examination for BCCs, palmar pits
- 05Chest X-ray, brain imaging in Gorlin
§ labsLaboratory Findings
- 01Aspirate soluble protein < 4 g/dL
- 02Keratin squames on cytology
- 03Immunopositive for CK-10, Bcl-2, PCNA, Ki-67 (10–35%)
§ ihcIHC / Special Stains
- 01Ki-67 index 10–35% (vs < 5% in other cysts)
- 02Bcl-2 basal positivity
- 03PTCH1 loss
- 04p53 overexpression in suprabasal layer
- 05CK-10 and CK-17 positive
§ whoWHO Classification
WHO 2017 & 2022: Odontogenic keratocyst — reclassified from Keratocystic Odontogenic Tumour (WHO 2005) back to a developmental odontogenic cyst.
§ classificationClassification
- 01Sporadic OKC (solitary)
- 02Syndromic OKC (Gorlin–Goltz — multiple, recurrent, syndromic features)
- 03Peripheral OKC (rare, extraosseous)
§ planTreatment Planning
- 01Confirm diagnosis by biopsy/aspiration
- 02Assess for syndromic features → dermatology + genetics referral
- 03CBCT for surgical planning
- 04Balance recurrence risk (up to 60% with enucleation alone) against morbidity of resection
§ treatmentTreatment
- 01Enucleation alone — recurrence 25–60%
- 02Enucleation + Carnoy's solution (modified, without CHCl3) — recurrence 8–10%
- 03Enucleation + peripheral ostectomy — recurrence 10–20%
- 04Enucleation + cryotherapy (liquid N2) — recurrence 11%
- 05Marsupialisation — reduces size, decreases recurrence when followed by enucleation
- 06Resection (segmental/marginal) for aggressive/recurrent OKCs — recurrence < 2% but greatest morbidity
- 07Vismodegib (SMO inhibitor) — experimental for Gorlin syndrome
§ medicalMedical Management
- 01Vismodegib 150 mg/day for multiple/inoperable syndromic OKCs (evidence emerging; alopecia, dysgeusia are common side effects)
§ surgicalSurgical Management
- 01Meticulous enucleation with intact lining is key
- 02Modified Carnoy's applied 3 min after enucleation
- 03Peripheral ostectomy 1–2 mm
- 04Marsupialisation with obturator for decompression
- 05Segmental resection with reconstruction plate + fibula flap for recurrent aggressive lesions
§ reconstructionReconstruction Options
- 01Guided bone regeneration for medium defects
- 02Iliac crest graft for large mandibular defects
- 03Free fibula flap for continuity defects after resection
§ complicationsComplications
- 01Recurrence (especially syndromic)
- 02IAN paraesthesia after aggressive treatment
- 03Pathologic fracture
- 04Ameloblastoma-like transformation (rare)
- 05Malignant transformation to SCC — reported but rare
§ recurrenceRecurrence Rate
Enucleation alone 25–60%; enucleation + adjunct 8–20%; resection < 2%. Peak recurrence within first 5 years; late recurrences up to 10 years described. Syndromic OKCs recur more often.
§ followupFollow-up Protocol
- 01Clinical + OPG every 6 months for 2 years
- 02Annually thereafter for a minimum of 10 years
- 03Lifelong review in Gorlin syndrome
- 04Genetic counselling for family members
§ prognosisPrognosis
Excellent for lifespan; recurrence and morbidity are the main issues. Syndromic OKCs require long-term surveillance.
§ preventionPrevention
- 01No primary prevention; secondary — surveillance in Gorlin families
- 02Genetic counselling
§ examKey Examination Points
- 01Grows along the bone; minimal expansion
- 02Aspirate protein < 4 g/dL, keratin flakes
- 03Corrugated parakeratin, palisaded basal layer, flat CT interface
- 04Always screen for Gorlin–Goltz syndrome
§ revisionQuick Revision Summary
- 01From rests of Serres, PTCH1 mutation
- 02Posterior mandible
- 03Grows anteroposteriorly, little expansion
- 04Parakeratinised, palisaded basal, flat CT junction
- 05High recurrence — enucleation + adjunct
- 06Multiple/young → screen Gorlin
§ vivaBDS Viva Questions
- 01Why was OKC renamed KCOT and then renamed back?
- 02Which gene is mutated?
- 03Describe histopathology of OKC.
- 04Why is recurrence high?
- 05Diagnostic criteria for Gorlin–Goltz syndrome.
- 06Composition of Carnoy's solution — old vs modified.
- 07Aspiration findings in OKC vs radicular cyst.
- 08Marsupialisation — indications and technique.
- 09How does OKC differ from dentigerous cyst radiographically?
- 10IHC markers for OKC.
- 11Role of vismodegib.
- 12Radiographic differential of multilocular mandibular radiolucency.
- 13Follow-up protocol.
- 14Why is peripheral ostectomy performed?
- 15What is a satellite cyst?
- 16Discuss malignant transformation.
- 17Complications of Carnoy's solution.
§ bdsBDS Professional Examination
- 01Long essay: Odontogenic keratocyst — aetiology, pathogenesis, clinical, radiographic and histopathological features, management and recurrence.
- 02Short essay: Gorlin–Goltz syndrome.
- 03Short note: Carnoy's solution.
- 04Short note: Marsupialisation.
§ fcpsFCPS Residency Questions
- 01Discuss the molecular basis of OKC and Gorlin–Goltz syndrome and its implications for targeted therapy.
- 02Evidence-based comparison of surgical modalities for OKC — recurrence and morbidity.
- 03A 22-year-old female presents with multiple jaw radiolucencies. Discuss investigation and management.
§ pearlsClinical Pearls
- 01'Empty' looking lesion on OPG in the mandibular ramus of a young patient — think OKC.
- 02Always screen for skin BCCs and palmar pits.
- 03Marsupialise big lesions, enucleate later — safer and lower recurrence.
§ mnemonicsMnemonics
- 01OKC = Only Kids Come (young age); PARA-K, PALI-sade, FLAT junction, SATELLITES = 4 histologic pillars
§ readingSuggested Reading
- 01WHO Classification of Head and Neck Tumours, 5e (2022) — Odontogenic cysts chapter
- 02Pogrel MA. The keratocystic odontogenic tumour: current concepts of pathogenesis and treatment. Oral Maxillofac Surg Clin N Am.
- 03Kaczmarzyk T et al. A systematic review of the recurrence rate for keratocystic odontogenic tumour. Int J Oral Maxillofac Surg 2012.
§ differentialDifferential Comparison
| Entity | Feature | Distinguisher |
|---|---|---|
| Dentigerous cyst | Attached CEJ, unilocular | Buccolingual expansion; parakeratin absent; recurrence rare |
| Ameloblastoma | Multilocular soap-bubble | Marked buccolingual expansion; ameloblast-like palisading; BRAF V600E |
| Aspirate | Thick cheesy/dirty white | Protein < 4 g/dL (vs > 5 in radicular cyst) |
§ mcqsMCQs — Assessment (20)
Question 1
The current (WHO 2022) classification of OKC is:
Question 2
Gene mutated in OKC and Gorlin syndrome:
Question 3
OKC arises from:
Question 4
Aspirate protein content in OKC:
Question 5
Characteristic histological feature:
Question 6
Most common site:
Question 7
Recurrence after enucleation alone is:
Question 8
Original Carnoy's solution contains all EXCEPT:
Question 9
Which is NOT a feature of Gorlin–Goltz syndrome?
Question 10
Ki-67 index in OKC is typically:
Question 11
Best imaging for surgical planning:
Question 12
Vismodegib acts on:
Question 13
Corrugated luminal surface is due to:
Question 14
Which growth pattern is characteristic?
Question 15
OKC is often mistaken for which cyst radiographically?
Question 16
Enucleation + peripheral ostectomy reduces recurrence to:
Question 17
Which of the following aspirates is characteristic of OKC?
Question 18
Which IHC is positive in OKC basal cells?
Question 19
Modified Carnoy's is applied for:
Question 20
Which of the following favours resection over enucleation?
References
- WHO Classification of Head and Neck Tumours, 5e (2022)
- Neville BW et al. Oral and Maxillofacial Pathology, 4e
- Shear M, Speight PM. Cysts of the Oral and Maxillofacial Regions, 4e
- Peterson LJ. Contemporary Oral & Maxillofacial Surgery, 7e
- Regezi JA, Sciubba JJ. Oral Pathology: Clinical Pathologic Correlations, 8e
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.